[HTML][HTML] Antibacterial Activity of Green Synthesized Silver Nanoparticles Using Lawsonia inermis Against Common Pathogens from Urinary Tract Infection
A Said, M Abu-Elghait, HM Atta, SS Salem - Applied Biochemistry and …, 2024 - Springer
New and creative methodologies for the fabrication of silver nanoparticles (Ag-NPs), which
are exploited in a wide range of consumer items, are of significant interest. Hence, this …
are exploited in a wide range of consumer items, are of significant interest. Hence, this …
[HTML][HTML] Innovative delivery and release systems for antioxidants and other active substances in the treatment of cancer
Z Sezgin-Bayindir, S Losada-Barreiro… - Pharmaceuticals, 2023 - mdpi.com
Cancer is one of the major diseases leading to death worldwide, and the fight against the
disease is still challenging. Cancer diseases are usually associated with increased oxidative …
disease is still challenging. Cancer diseases are usually associated with increased oxidative …
[HTML][HTML] The involvement of photobiology in contemporary dentistry—A narrative review
Light is an emerging treatment approach that is being used to treat many diseases and
conditions such as pain, inflammation, and wound healing. The light used in dental therapy …
conditions such as pain, inflammation, and wound healing. The light used in dental therapy …
[HTML][HTML] Multi-step in silico discovery of natural drugs against COVID-19 targeting main protease
In continuation of our antecedent work against COVID-19, three natural compounds, namely,
Luteoside C (130), Kahalalide E (184), and Streptovaricin B (278) were determined as the …
Luteoside C (130), Kahalalide E (184), and Streptovaricin B (278) were determined as the …
[HTML][HTML] A multistage in silico study of natural potential inhibitors targeting SARS-CoV-2 main protease
Among a group of 310 natural antiviral natural metabolites, our team identified three
compounds as the most potent natural inhibitors against the SARS-CoV-2 main protease …
compounds as the most potent natural inhibitors against the SARS-CoV-2 main protease …
[HTML][HTML] In Silico Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10
In continuation of our previous effort, different in silico selection methods were applied to
310 naturally isolated metabolites that exhibited antiviral potentialities before. The applied …
310 naturally isolated metabolites that exhibited antiviral potentialities before. The applied …
[HTML][HTML] New Anticancer Theobromine Derivative Targeting EGFRWT and EGFRT790M: Design, Semi-Synthesis, In Silico, and In Vitro Anticancer Studies
Based on the pharmacophoric features of EGFR inhibitors, a new semisynthetic
theobromine-derived compound was designed to interact with the catalytic pocket of EGFR …
theobromine-derived compound was designed to interact with the catalytic pocket of EGFR …
Design, semi-synthesis, anti-cancer assessment, docking, MD simulation, and DFT studies of novel theobromine-based derivatives as VEGFR-2 inhibitors and …
A group of theobromine derivatives was designed based on the key pharmacophoric
characteristics of VEGFR-2 inhibitors. HepG2 and MCF-7 cancer cell lines were used to test …
characteristics of VEGFR-2 inhibitors. HepG2 and MCF-7 cancer cell lines were used to test …
[HTML][HTML] In Silico Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular …
Papain-like protease is an essential enzyme in the proteolytic processing required for the
replication of SARS-CoV-2. Accordingly, such an enzyme is an important target for the …
replication of SARS-CoV-2. Accordingly, such an enzyme is an important target for the …
Anti-breast cancer potential of a new xanthine derivative: in silico, antiproliferative, selectivity, VEGFR-2 inhibition, apoptosis induction and migration inhibition studies
Background The overexpression of VEGFR-2 receptors in breast cancer provides a valuable
approach to anticancer strategies. Targeting VEGFR-2, a new semisynthetic compound (T-1 …
approach to anticancer strategies. Targeting VEGFR-2, a new semisynthetic compound (T-1 …